Lateral Flow Assays Market worth $10.2 billion by 2025 - Exclusive Report by MarketsandMarkets™

CHICAGO, Nov. 17, 2020 /PRNewswire/ -- According to the new market research report "Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025", published by MarketsandMarkets™, the Lateral Flow Assays Market is projected to reach USD 10.2billion by 2025 from 8.2 billion in 2020, at a CAGR of 4.5% during the forecast period.

Browse in-depth TOC on "Lateral Flow Assays Market"

323 – Tables
56 – Figures
346 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133

The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market. However, other reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key factors restraining the growth of the market.

By product, the kits & reagents segment is expected to account for the largest share of the Lateral Flow Assays market

Based on product, the market is segmented into kits & reagents and lateral flow readers. The lateral flow readers segment is further segmented into digital/handheld readers, bench top readers, and mobile/smartphone readers. The kits & reagents segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for POC testing, the growing burden of chronic diseases, and their convenience and ease of use.

On the basis of application, the food safety &environment testing segment is expected to grow at the highest CAGR in the forecast period

On the basis of application, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety and environment testing & drug development and quality testing. The food safety and environment testing segment is expected to grow at the fastest rate in the forecast period. The high growth rate of this segment is due to increasing food safety issues and concerns in many sections of the food production industry and wide applications of environment testing due to their ability to handle a wide variety of samples and perform many sample-handling tasks, such as filtration, concentration, and removal of the cross-reactive element.

In case of lateral flow assays kits & reagents, by technique, the sandwich assays segment is expected to hold the highest share in the market during the forecast period

On the basis of technique, the Lateral Flow Assays kits & reagents market is segmented into sandwich assays, competitive assays, and multiplex detection assays. The sandwich assays segment is expected to hold the highest share in the market during the forecast period. The large share of this segment can be attributed to its better assay sensitivity and specificity as well as its extensive application in the measurement of critical analytes (such as cardiac and hepatitis markers).

By Sample Type, Other Samples is projected to grow at the highest rate during the forecast period.

By Type, Lateral Flow Assays is segment in to Blood Samples, Urine Samples, Saliva Samples and Other Samples. The Other Samples segment is projected to grow at the higher CAGR during the forecast period. The high growth of the Other Samples segment can be attributed to increase in R&D and the need for more specific and accurate disease testing.

By End User, hospitals and clinics to dominate the Lateral Flow Assays market during the forecast period

By End User, Lateral Flow Assay market is segmented into Hospitals & Clinics, Home Care Settings, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Other End Users. The Hospitals and Clinics segment is expected to dominate the market in the forecast period. Technological advancements, increasing adoption of point-of-care testing, and the growing inclination toward fast and early diagnosis, especially in relation to the current COVID-19 scenario, are some of the key factors responsible for the highest share of this segment.

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133

North America to dominate the Lateral Flow Assays market during the forecast period

North America is expected to account for the largest share of the Lateral Flow Assay market in 2019, followed by Europe. The dominance of the North American region can be attributed to, increasing R&D investment in the region and presence of a large number of market players.

Prominent players in the Lateral Flow Assaysmarket include Abbott Laboratories (US), F.Hoffman La-Roche Ltd. (Switzerland), Danaher Corporation(US), Becton, Dickinson, and Company (US), Siemens AG (Germany) &Thermofisher Scientific (US)

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Get Special Pricing on Bundle Reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=167205133

Browse Related Reports:

Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024

https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com 
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/lateral-flow-assay-market.asp 
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/lateral-flow-assay.asp

Logo : https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg